ENTPD1 and familial pancreatic carcinoma: Expression of CD39 and CD73 has been identified in various human tumors, including in kidney cancer, ovarian cancer, testicular cancer, pancreatic cancer, lung cancer, thyroid cancer, lymphoma, sarcoma, and leukemia [7–10].